Tags

Type your tag names separated by a space and hit enter

[Telemedicine in rheumatology].
Z Rheumatol. 2020 Nov; 79(9):883-892.ZR

Abstract

Due to the outbreak of the COVID-19 pandemic, in recent months we have experienced deep changes in our daily and professional lives. In the context of pandemic containment, routine rheumatological procedures have changed in many areas. To guarantee sufficient protection against the infection for patients and staff, telemedicine (especially telephone and video consultation) has increasingly been used. Due to the Digital Healthcare Act (DiGAV), whereby patients will have a legal claim to specific digital health applications in Germany, medical apps and wearables will offer new opportunities for telemedical monitoring. This article provides an overview of telemedical care options in the field of rheumatology. Furthermore, opportunities and limitations of telemedicine in rheumatology are reviewed.

Authors+Show Affiliations

Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité Universitätsmedizin, Charitéplatz 1, 10117, Berlin, Deutschland. martin.krusche@charite.de.Zentrum für Versorgungsforschung Brandenburg, Medizinische Hochschule Brandenburg Theodor Fontane, Neuruppin, Deutschland. Fakultät für Gesundheitswissenschaften Brandenburg, Potsdam, Deutschland.Rheumatologie im Struenseehaus, Hamburg, Deutschland.MVZ für Rheumatologie Dr. Martin Welcker GmbH & RheumaDatenRhePort (RhaDaR), Planegg, Deutschland.Medizinische Klinik 3 - Rheumatologie und Immunologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Deutschland.

Pub Type(s)

Journal Article

Language

ger

PubMed ID

33057786

Citation

Krusche, M, et al. "[Telemedicine in Rheumatology]." Zeitschrift Fur Rheumatologie, vol. 79, no. 9, 2020, pp. 883-892.
Krusche M, Mühlensiepen F, Aries P, et al. [Telemedicine in rheumatology]. Z Rheumatol. 2020;79(9):883-892.
Krusche, M., Mühlensiepen, F., Aries, P., Welcker, M., & Knitza, J. (2020). [Telemedicine in rheumatology]. Zeitschrift Fur Rheumatologie, 79(9), 883-892. https://doi.org/10.1007/s00393-020-00912-1
Krusche M, et al. [Telemedicine in Rheumatology]. Z Rheumatol. 2020;79(9):883-892. PubMed PMID: 33057786.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Telemedicine in rheumatology]. AU - Krusche,M, AU - Mühlensiepen,F, AU - Aries,P, AU - Welcker,M, AU - Knitza,J, Y1 - 2020/10/15/ PY - 2020/09/21/accepted PY - 2020/10/16/pubmed PY - 2020/11/12/medline PY - 2020/10/15/entrez KW - Apps KW - Digitalization KW - Telephone consultation KW - Video consultation KW - Wearables SP - 883 EP - 892 JF - Zeitschrift fur Rheumatologie JO - Z Rheumatol VL - 79 IS - 9 N2 - Due to the outbreak of the COVID-19 pandemic, in recent months we have experienced deep changes in our daily and professional lives. In the context of pandemic containment, routine rheumatological procedures have changed in many areas. To guarantee sufficient protection against the infection for patients and staff, telemedicine (especially telephone and video consultation) has increasingly been used. Due to the Digital Healthcare Act (DiGAV), whereby patients will have a legal claim to specific digital health applications in Germany, medical apps and wearables will offer new opportunities for telemedical monitoring. This article provides an overview of telemedical care options in the field of rheumatology. Furthermore, opportunities and limitations of telemedicine in rheumatology are reviewed. SN - 1435-1250 UR - https://news.unboundmedicine.com/medline/citation/33057786/[Telemedicine_in_rheumatology]. L2 - https://dx.doi.org/10.1007/s00393-020-00912-1 DB - PRIME DP - Unbound Medicine ER -